STK11 and esophageal squamous cell carcinoma: For example, it only explored the effects of immunotherapy on the levels of related factors and immune cells in patients with ESCC, but it could not prove that the STK11/AMPK signaling pathway can directly participate in the immunotherapy effect of ESCC.